Joseph C Papa Bausch Health Companies Inc. (BHC) insider trading activity

Joseph C Papa is Director of Bausch Health Companies Inc.. Currently has a direct ownership of 1.43 Million shares of BHC, which is worth approximately $14 Million. The most recent transaction as insider was on May 10, 2022, when has been sold 33,714 shares (Common Shares, no par value) at a price of $9.4 per share, resulting in proceeds of $316,912. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.43M

0% 3M change

0% 12M change

Total Value Held $14 Million

JOSEPH C PAPA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 10 2022	SELL Payment of exercise price or tax liability	$316,912 $9.4 p/Share	33,714 Reduced 2.31%	1,427,568 Common Shares, no par ...
May 10 2022	BUY Exercise of conversion of derivative security	-	366,130 Added 20.04%	1,461,282 Common Shares, no par ...
Mar 03 2022	SELL Payment of exercise price or tax liability	$298,501 $23.61 p/Share	12,643 Reduced 1.14%	1,095,152 Common Shares, no par ...
Feb 28 2022	SELL Payment of exercise price or tax liability	$123,067 $24.06 p/Share	5,115 Reduced 0.46%	1,107,795 Common Shares, no par ...
Feb 27 2022	SELL Payment of exercise price or tax liability	$2,765,113 $24.35 p/Share	113,557 Reduced 9.26%	1,112,910 Common Shares, no par ...
Feb 27 2022	BUY Exercise of conversion of derivative security	-	208,231 Added 14.38%	1,239,650 Common Shares, no par ...
Feb 26 2022	SELL Payment of exercise price or tax liability	$321,006 $24.35 p/Share	13,183 Reduced 1.16%	1,126,116 Common Shares, no par ...
Sep 14 2021	SELL Payment of exercise price or tax liability	$143,587 $28.66 p/Share	5,010 Reduced 0.48%	1,031,419 Common Shares, no par ...
Sep 13 2021	SELL Payment of exercise price or tax liability	$103,595 $29.19 p/Share	3,549 Reduced 0.34%	1,036,429 Common Shares, no par ...
Mar 10 2021	SELL Payment of exercise price or tax liability	$7,622,269 $32.97 p/Share	231,188 Reduced 18.19%	1,039,978 Common Shares, no par ...
Mar 08 2021	BUY Grant, award, or other acquisition	-	108,254 Added 7.85%	1,271,166 Common Shares, no par ...
Mar 08 2021	BUY Exercise of conversion of derivative security	-	317,089 Added 21.42%	1,162,912 Common Shares, no par ...
Mar 03 2021	BUY Grant, award, or other acquisition	-	74,150 Added 8.06%	845,823 Common Shares, no par ...
Mar 01 2021	SELL Payment of exercise price or tax liability	$885,793 $31.42 p/Share	28,192 Reduced 3.52%	771,673 Common Shares, no par ...

Also insider at

RXDX

Prometheus Biosciences, Inc. Healthcare

Director

BLCO

Bausch & Lomb Corp Healthcare

CEO & Chairman

CADL

Candel Therapeutics, Inc. Healthcare

EBS

Emergent BioSolutions Inc. Healthcare

President and CEO

MIST

Milestone Pharmaceuticals Inc. Healthcare

JCP

Joseph C Papa

Director

Needham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Value

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC

Account